Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02893371 · ClinicalTrials.gov registry record
Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies
A clinical trial, sponsored by University of New Mexico.
- Terminated
- Registry status
- 1,037,352
- Enrollment target
NCT02893371: Clinical Trial study, sponsored by University of New Mexico.
NCT02893371 is a clinical trial that was terminated before completion, run by University of New Mexico. The registered enrollment target is 1,037,352 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02893371 was terminated before completion, sponsored by University of New Mexico.
- TERMINATED
- Registry status
- 1,037,352 participants
- Enrollment target
Study Summary
The objective of this retrospective observational study is to compare commonly prescribed bipolar disorder medications for their impact on: (1) hospitalization; (2) suicide attempts and self-harm; and (3) risk of drug-induced adverse effects such as kidney disease and diabetes mellitus. In addition, the investigators will examine heterogeneity of treatment effect by co-morbidity within pediatric, adult, and elderly sub-populations. Patient focus groups are convened to elicit additional questions and provide feedback on results.
Primary Outcome
For each treatment, assess the risk of rehospitalization within 30-days after hospitalization for a mood episode. For each treatment, assess the cumulative incidence of hospitalization for a mood episode any time after commencing treatment, accounting for the competing risk of ending treatment.
Interventions
- DRUG Lamotrigine
- DRUG Oxcarbazepine
- DRUG Valproic Acid
- DRUG Carbamazepine
- DRUG Lithium Carbonate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,037,352 participants |
| Start Date | 2016-09 |
| Est. Completion | 2019-06-30 |
Why NCT02893371 stopped before completion
NCT02893371 is an observational study that tracks outcomes without assigning an intervention. Its 1,037,352 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 5 interventions - of which Lamotrigine is the first listed.
NCT02893371 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02893371 about?
NCT02893371 is a clinical study titled "Longitudinal Comparative Effectiveness of Bipolar Disorder Therapies". The objective of this retrospective observational study is to compare commonly prescribed bipolar disorder medications for their impact on: (1) hospitalization; (2) suicide attempts and self-harm; and (3) risk of drug-induced adverse effects such as kidney disease and diabetes mellitus. In addition,...
What is the current status of trial NCT02893371?
This trial is currently terminated. The enrollment target is 1,037,352 participants. The study started on 2016-09. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02893371?
The interventions under investigation include: Lamotrigine (DRUG), Oxcarbazepine (DRUG), Valproic Acid (DRUG), Carbamazepine (DRUG), Lithium Carbonate (DRUG).
Who is sponsoring clinical trial NCT02893371?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05066763 · 1,000,000 participants
Parkinson's Foundation Surveys
- NCT07075341 · 1,000,000 participants
Healthy Living BEYOND Weight Study
- NCT07224685 · 1,000,000 participants
A Study of Mayo Clinic CV Research Heart & Voice Study
- NCT06029933 · 960,000 participants
Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia